Your first 90 days
Your first 90 days on Cuvrior for Wilson disease
What happens before the first fill, the days that matter, the label's rules and who to call, from the label, the drugmaker's own program and one insurer's written rules.
Cuvrior is a switch for people already treated, not a first treatment for Wilson disease. The label covers adults whose Wilson disease is already stable on penicillamine. It gives a table for turning the old dose into the new one. The hard part of the first months is timing, since each dose needs an empty stomach and space from other pills. This page lays out those 3 months from the FDA label, Orphalan's Navigator Program and one insurer's written rules.
What has to happen before the first bottle ships
Cuvrior has no REMS, so the first fill waits on a conversion from penicillamine, a Start Form and an insurance approval through one specialty pharmacy. These are the 6 things in the way, in order.
A check that Cuvrior fits your situation
The label approves Cuvrior for adults with stable Wilson disease who are de-coppered and tolerate penicillamine.
- It says safety and effectiveness in children have not been established.
- Your hepatologist decides whether a switch makes sense for you.FDA label
A new dose worked out from your penicillamine dose
The label gives a table that turns each penicillamine dose into a Cuvrior starting dose.
- Someone on 1,000mg of penicillamine a day, for example, starts at 2,100mg of Cuvrior a day.
- The label says penicillamine is stopped before Cuvrior starts, and the prescriber sets the timing.FDA label
A different count if you take another trientine
Cuvrior is not swapped milligram for milligram with trientine hydrochloride capsules.
- A 250mg capsule holds 167mg of the active trientine, while a 300mg Cuvrior tablet holds 150mg.
- The prescriber works out a new count rather than copying the old dose.FDA label
The Start Form, which enrolls you
The preferred way to start is the Navigator Program Start Form, which serves as the prescription and enrolls you in the program.
- Orphalan says patient consent may be required for some program offers.
- An electronic prescription sent on its own does not enroll you in the program.Prescribing Cuvrior
The insurance approval
When the plan allows, PANTHERx Rare starts an electronic prior authorization through CoverMyMeds for the prescriber's office to complete.
- The office sends chart notes and lab results with it.
- Orphalan's guide says the pharmacy cannot submit the request or write the letter of medical necessity itself.Reimbursement Guide
If the insurance decision is slow
The Quick Start Program can send a free 30-day supply to insured adults new to Cuvrior whose coverage has been delayed at least 5 days.
- A one-month refill of that free supply is available if the delay continues.
- The prescriber attests that you have been de-coppered and have not taken Cuvrior before.Start Form
The days that matter
Counted from the first dose, with the paperwork before it, refills that depend on your tablet count, and the label's copper tests. Type your first-dose date and the tiles become real dates you can add to your calendar.
The tiles below count days from a first dose. Enter the date of yours, or the date you expect, and each tile becomes a real date on your calendar.
The date stays on your device. It is not sent to Trial Friend or anyone else. The calendar file works with Apple, Google and Outlook calendars.Start Form sent, Care Coordinator assigned
The prescriber's office sends the Start Form with copies of both sides of your insurance cards.
- A dedicated Care Coordinator then explains your coverage and the steps your plan requires.
Prior authorization and the pharmacy's call
PANTHERx Rare starts the prior authorization where it can and coordinates shipping once the plan approves.
- Orphalan's Quick Start Program can supply eligible patients at no cost for a limited time while coverage is decided.
Penicillamine stops, by the label
The label says penicillamine is stopped before the first Cuvrior dose.
- Your hepatologist tells you when the last penicillamine dose falls and when Cuvrior begins.
First dose, and the first copper test
The day's tablets are split into 2 doses, with any extra tablet taken in the morning.
- The label calls for a blood test of non-ceruloplasmin copper when Cuvrior starts, which your prescriber schedules.
Two weeks in
The label warns that Wilson disease symptoms, including neurological symptoms, can get worse at the start of treatment.
- This is a reasonable point to tell the office what has changed and confirm the next shipment.
Refill, if the first fill was 30 days
The Quick Start prescription on the Start Form is a 30-day supply with 1 refill.
- The ongoing prescription's supply length is set by the prescriber, so ask PANTHERx Rare when the next shipment comes.
Refill, number 2
Blood copper test at 3 months
The label calls for a serum non-ceruloplasmin copper test after 3 months of treatment.
- The hepatologist adjusts the dose using that result and how you are doing.
Refill, number 3
Copper tests about every 6 months
After the 3-month test, the label calls for the blood copper test about every 6 months.
- A 24-hour urine copper collection may also be done every 6 to 12 months.
The label, revision by revision
The FDA lists which sections changed in each revision of a label. These are the revisions the current Cuvrior label records, dated by the FDA, with a plain note on what each one meant for a patient. Older references and handouts can lag these by months.
Current label dated June 19, 2025, read from the FDA's label database today. FDA label
- June 2025
The current version of the label on DailyMed carries the date June 19, 2025. Its highlights still read revised January 2024, with no recent major changes and no boxed warning.FDA label
- April 2022
The dosing table, food and medicine spacing, copper test schedule and warnings in the current label read the same as in this first label.FDA label, 2022
How the label says to take it
The parts of the prescribing information and the patient leaflet that come up in the first 3 months, in plain words.
- Twice a day, on an empty stomach
The label says to take Cuvrior at least 1 hour before meals or 2 hours after meals.
- It also asks for at least 1 hour between Cuvrior and any other food or milk.FDA label
- More tablets in the morning when the count is odd
When the day's tablets cannot be split evenly, the higher number goes with the first dose.
- At 2,100mg a day, for example, that is 4 tablets in the morning and 3 in the evening.FDA label
- An hour away from other pills
The label says to take Cuvrior at least 1 hour apart from any other medicine taken by mouth.
- Cuvrior can bind minerals in other medicines, and the label says it could then stop working before it is absorbed.FDA label
- Mineral supplements
The label says to avoid iron, zinc, calcium and magnesium supplements with Cuvrior.
- If iron cannot be avoided, Cuvrior goes at least 2 hours before or after it.
- Cuvrior goes at least 1 hour before or 2 hours after other minerals.FDA label
- Swallowed whole, from the blister at dose time
The label says to swallow the tablets without crushing, chewing or dissolving them.
- A scored tablet can be split into 2 halves for anyone who has trouble swallowing it.
- Tablets stay in the blister until the moment of the dose.FDA label
- If a dose is missed
The label does not say what to do after a missed dose of Cuvrior.
- Ask the hepatologist or the pharmacist ahead of time what they want you to do.FDA label
- Pregnancy and breastfeeding
The label says untreated Wilson disease, or stopping treatment during pregnancy, may worsen liver and nerve symptoms.
- It asks prescribers to check copper levels throughout pregnancy and use the lowest effective dose.
- Tell the hepatologist about a pregnancy or plans for one.
- On breastfeeding, the label says published data are inconsistent and asks for the benefits and risks to be weighed.FDA label
- Storage
The label says to store Cuvrior at 68 to 77 degrees Fahrenheit.
- Each small carton is child-resistant, and an opened tablet should not be saved for later.FDA label
What the label says to act on
The symptoms the label singles out, and what it tells patients and prescribers to do about each. If any of these happen, the label's instruction is the one to follow, with your care team.
Symptoms that get worse at the start
The label says Wilson disease symptoms, including neurological ones, may worsen when Cuvrior begins because stored copper is being moved.
- It tells patients to report this, and the prescriber may change the dose or stop Cuvrior.FDA label
A rash or other allergic reaction
The label reports a rash in 3 of 26 people on Cuvrior in the main study, and 1 of them stopped because of it.
- The label tells patients to report a rash or other allergic reaction.FDA label
What Orphalan says to do about a rash
Orphalan's patient page says to contact your doctor immediately or get emergency help if a rash or other allergic reaction occurs.Navigator Program
Low copper or low iron
The label warns that copper deficiency and iron deficiency can develop on Cuvrior.
- Iron deficiency is more likely in people who menstruate or are pregnant.
- The label tells patients to report any signs of either to their healthcare provider.FDA label
The most common side effects
In the 24-week study, stomach pain affected 19% of people on Cuvrior against 4% on penicillamine.
- Changes in bowel habits affected 15%, rash 12%, hair loss 8% and mood swings 8%.FDA label
Why the pharmacy or the insurer says no, and what fixes it
Most first-fill delays are one of these. Knowing which one tells you who to call.
- The prescription went to another pharmacyOrphalan says Cuvrior is available only through PANTHERx Rare Pharmacy. The prescriber's office resends the Start Form or an electronic prescription there. This is a routing problem for the office to fix, not an insurance denial.Prescribing Cuvrior
- The Navigator offers never startedAn electronic prescription starts the insurance check but does not enroll you in the Navigator Program. The Start Form does both, and your signature on it lets the program check which offers fit you.Prescribing Cuvrior
- Prior authorization pending or deniedCigna's policy, reviewed December 10, 2025, asks for a confirmed diagnosis, a liver or digestive specialist, and one of 6 reasons for trientine. If coverage is delayed at least 5 days, an eligible patient may get a free 30-day Quick Start supply.Cigna policy
- The plan's reasons do not fit a switchCigna's 6 reasons include penicillamine intolerance, neurologic symptoms, pregnancy and already taking trientine. The Cuvrior label's own group, stable adults who tolerate penicillamine, is not named among them.Cigna policy
- The appeal was deniedOrphalan's guide says an appeal includes the denial letter, chart notes and a letter of medical necessity. Once all appeals are used up, including an external review, a patient may qualify for free medicine through the Patient Assistance Program.Reimbursement Guide
- A copay you cannot payEligible patients with commercial insurance may pay as little as $0 per fill, up to an annual cap Orphalan does not publish. Medicare, including Part D, Medicaid, TRICARE and VA coverage are excluded from the copay program.Copay terms
Cigna prior authorization policy, December 10, 2025
- Wilson disease confirmed by genetic testing showing disease-causing changes in both copies of ATP7B, or by at least 2 of these: Kayser-Fleischer rings, serum ceruloplasmin under 20mg/dL, a liver biopsy consistent with Wilson disease, 24-hour urine copper over 40mcg
- At least 1 of 6 reasons: penicillamine intolerance, features suggesting possible intolerance, a reason penicillamine cannot be used, neurologic symptoms, pregnancy, or already started on trientine
- Prescribed by or with a gastroenterologist, hepatologist or liver transplant physician
Approval length. A year at a time; the policy covers both Cuvrior and trientine hydrochloride capsules with the same criteria.
This Cigna National Formulary policy was reviewed in December 2025 and cites the June 2025 Cuvrior label, so it postdates the current label. Its 6 reasons were written for trientine in general and do not name the Cuvrior label's own group, adults stable and tolerant on penicillamine. Other plans set their own criteria, and this one is here as an example of what a plan asks for, not as a rule. Cigna policy
Who to call, and what they can do
The drugmaker's program handles most of the first-fill problems above. Charity funds and foundation help are on the help paying page.
- A dedicated Care Coordinator who gives education and support about getting your medicine
- The Quick Start Program, a free 30-day supply plus a one-month refill for insured adults new to Cuvrior whose coverage has been delayed at least 5 days Start Form
- A copay program for commercial or private insurance, as little as $0 per fill up to an annual cap, not valid with Medicare, including Part D, Medicaid, TRICARE or VA Copay terms
- A Patient Assistance Program for people who are uninsured or underinsured, after enrollment and a financial assessment
- Delivery from PANTHERx Rare Pharmacy, the only pharmacy that dispenses Cuvrior Prescribing Cuvrior
Details as the drugmaker publishes them. Navigator Program
Five questions for the pharmacist or the support line
- Has PANTHERx Rare received my Start Form, and is anything still missing before you can ship?
- How many tablets a day is my dose, and how many cartons will each shipment hold?
- These are my other medicines and supplements, so how should I space each of them from Cuvrior?
- The label does not say what to do after a missed dose, so what should I do if one is missed?
- If my hepatologist changes the dose after a copper test, when does the new count start?
Questions people ask in the first weeks
How do I switch from penicillamine to Cuvrior?
The label says penicillamine is stopped before Cuvrior starts, and it gives a table for the starting dose. Each penicillamine dose maps to a Cuvrior dose between 300mg and 3,000mg a day. The hepatologist sets the starting dose and the day the switch happens.
When should I take Cuvrior?
The label says twice a day on an empty stomach, at least 1 hour before meals or 2 hours after them. Other food, milk and other medicines stay at least 1 hour away from each dose.
Can I take Cuvrior with zinc, iron or calcium?
The label says to avoid iron, zinc, calcium and magnesium supplements with Cuvrior. When iron cannot be avoided, Cuvrior goes at least 2 hours before or after it. Cuvrior goes at least 1 hour before or 2 hours after other minerals.
Is Cuvrior the same dose as my old trientine?
No, the label says Cuvrior is not swapped milligram for milligram with other trientine products. A 250mg trientine hydrochloride capsule holds 167mg of active trientine, while a 300mg Cuvrior tablet holds 150mg.
What blood tests are needed on Cuvrior?
The label sets a serum non-ceruloplasmin copper test at the start, after 3 months, and about every 6 months after that. A 24-hour urine copper collection may also be done every 6 to 12 months.
Where do I get Cuvrior filled?
Orphalan says Cuvrior is available only through PANTHERx Rare Pharmacy, which coordinates shipping once the insurance steps are done. The Navigator Program's Care Coordinators can be reached at 1-877-995-6774.
Why was Cuvrior denied by my insurance?
Cigna's December 2025 policy asks for a confirmed diagnosis, a liver or digestive specialist and one of 6 reasons for trientine. Those reasons do not name the label's own group of stable adults who tolerate penicillamine. Orphalan's guide describes appeals with chart notes and a letter of medical necessity.
Is Cuvrior approved for children?
No, the label says safety and effectiveness in children have not been established. At approval, the FDA asked Orphalan for a study in children that includes half-tablet dosing for young children.
Free email alert
Hear when the Cuvrior label changes
One email the day the FDA revises the Cuvrior label, with what changed in plain words. No trial alerts, no newsletter.
Label changes for Cuvrior only, usually a few a year and some years none. Stop anytime. We never share your email. Privacy policy
Want the whole condition instead? Follow Wilson disease for new trials, FDA decisions and label changes for every treatment.
Sources
- CUVRIOR- trientine tetrahydrochloride tablet, film coated, prescribing information, highlights revised 1/2024, DailyMed version 7, Orphalan SA, via DailyMed, June 19, 2025.
- CUVRIOR (trientine tetrahydrochloride) tablets, for oral use, prescribing information, Revised 4/2022, FDA, Drugs@FDA, April 28, 2022.
- NDA 215760 approval letter, Cuvrior (trientine tetrahydrochloride) tablets, FDA, April 28, 2022.
- Prescribing CUVRIOR, Orphalan, November 9, 2026.
- Navigator Program Start Form, US-ORPH-CUVR-25005, June 2025, Orphalan, November 9, 2026.
- Navigator Program Terms & Conditions, Orphalan, November 9, 2026.
- Navigator Program Reimbursement Guide, US-ORPH-CUVR-24060, July 2024, Orphalan, November 9, 2026.
- Chelating Agents, Trientine Products Prior Authorization Policy, Cigna National Formulary Coverage, Cigna, December 10, 2025.
- CHELATE STUDY: Trientine Tetrahydrochloride (TETA 4HCL) for the Treatment of Wilson's Disease, NCT03539952, ClinicalTrials.gov, record updated July 2, 2025, July 2, 2025.
This page explains what the FDA label, the drugmaker's support program and an insurer policy say. It is not medical advice and does not tell anyone to start, stop or change a medicine. Dosing, test timing and restarts after a gap are decisions for the prescribing hepatologist. Found an error? Use the report link in the footer and it will be checked against the source.